• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corporation Common Stock (NY:GKOS)

    163.47 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Sep 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Glaukos Corporation Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today ↗
    Glaukos (NYSE:GKOS) has outperformed the market over the past 10 years by 3.9% on an annualized basis producing an average annual return of 17.45%. Currently, Glaukos has a market capitalization of... 
    Via Benzinga
    Glaukos (NYSE:GKOS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
    Via Chartmill
    News headline image
    Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today ↗
    Glaukos (NYSE:GKOS) has outperformed the market over the past 5 years by 15.09% on an annualized basis producing an average annual return of 26.17%. Currently, Glaukos has a market capitalization of... 
    Via Benzinga
    News headline image
    Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗
    iDose TR drove $74M in Q2 revenue as Glaukos raised full-year guidance. 
    Via The Motley Fool
    Topics Earnings
    GKOS (Glaukos Corp) Shows Strong Trend Template Compliance and High Growth Momentum on ChartMill ↗
    Via Chartmill
    Glaukos Corp (NYSE:GKOS) Shares Surge on Record Sales and Raised Guidance After Q1 Beat ↗
    Via Chartmill
    Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
    Via Chartmill
    Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗
    Via Chartmill
    News headline image
    Glaukos Q2 Earnings Call Highlights ↗
    Glaukos (NYSE:GKOS) reported record second-quarter 2026 consolidated net sales of $185.6 million, up 50% from the prior-year period on a reported basis and 49% on a constant-currency basis, as growth... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? ↗
    Disposition represented 19% of insider's equity holdings under pre-established Rule 10b5-1 trading plan. Thurman retains 43,681 shares worth approximately $6.77 million. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? ↗
    Abbott trades at a fraction of Glaukos' valuation, but one company burns cash while the other generates billions. 
    Via The Motley Fool
    News headline image
    Glaukos (GKOS) Q1 2026 Earnings Transcript ↗
    Glaukos (GKOS) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
    This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
    Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
    This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline. 
    Via The Motley Fool
    News headline image
    CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
    This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
    BrightSpring Health Services delivers integrated pharmacy and clinical care to Medicare, Medicaid, and insured patients nationwide. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗
    Glaukos (GKOS) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Director Sells GKOS 15,000 Shares for $1.9 Million ↗
    This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock. 
    Via The Motley Fool
    Topics Regulatory Compliance
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
    Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
    The company's recent past featured robust growth, and it anticipates continued rises into the near future. 
    Via The Motley Fool
    News headline image
    Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
    Glaukos (GKOS) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
     
    Via Benzinga
    News headline image
    Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Why Glaukos Stock Jumped Over 20% After-Hours Today ↗
    Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance. 
    Via Stocktwits
    News headline image
    What's going on in today's after hours session ↗
    The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.